LARP1B

Across TCGA pan-cancer cohorts, LARP1B mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LARP1B data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LARP1B mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated LARP1B expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.

UCEC, CCRCC, and HNSC are the cancer types where LARP1B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.866	0.531	.026	20	view →
CCRCC	DFS	Median	II,III,IV	0.295	0.827	.010	15	view →
HNSC	DFS	Quartile	All	0.851	0.570	.005	7	view →
LUAD	DFS	Median	All	0.899	1.000	.027	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LARP1B–UCEC (DFS)

Open the UCEC breakdown →